Research by IRBLleida and the UdL lays the foundations for possible future combined therapies by identifying a death pathway in tumour cells Glioblastoma is the most common and aggressive brain cancer, due to its ability to evade the immune system and grow. The Calcium …

According to research led by psychiatrists from the University Hospital Santa Maria and the IRBLleida Healthy lifestyle habits and a correct diet improve the cognitive evolution of patients with bipolar disorder, according to the conclusions of a research project led by psychiatrists from the University …

According to the World Health Organization (WHO), non-communicable diseases kill 41 million people every year. These include a wide range of metabolic diseases, such as obesity and its associated diseases (type 2 diabetes, fatty liver disease), and other diseases with a strong inflammatory component, such …

The study, led by Dr. Jordi Mayneris-Perxachs and Dr. José Manuel Fernández-Real, head of the Nutrition, Eumetabolism and Health group at the IDIBGI, finds a greater presence of these viruses in people who eat dairy products in their regular diet.The work, published in the journal Cell …

Some data on diabetic retinopathy – a rather unknown disease linked to diabetes Diabetes is a little-known, yet leading cause of blindness in Europe.It was estimated that  64 million people have diabetes in the European Region[i] in 2016 or representing around 7% of the Regional …

Researchers at the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida) have developed a free application to monitor the SARS-CoV-2 pandemic. Created as part of the UdL’s IlerCOVID research project, COVIDWORLD allows the current situation of the virus in 238 Spanish …

“RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) is a new Horizon Europe project led by the biotech pharmaceutical company HIPRA. Launched on 1st December, RBDCOV project objective is to test the efficacy, tolerability, and safety of the HIPRA’s recombinant …

Photo by Piron Guillaume on Unplash …

Research led by the Departments of Dermatology, Pathology and Molecular Genetics of the Hospital Universitari Arnau de Vilanova de Lleida (HUAV) and the Oncological Pathology research group of the Universitat de Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida) has identified …

Lleida, through the Clinical Trials unit of the Biomedical Research Institute of Lleida (IRBLleida), is participating in the Destiny-Breast clinical trials programme to tackle HER2+ breast cancer. Specifically, it has participated in Destiny-Breast 2 and is currently participating in Destiny-Breast 5, which involves patients with …

The use of emerging senolytic drugs, which attack senescent or ageing cells, could improve people who have suffered an ischaemic stroke due to a lack of blood flow to the brain. This is according to research by the University of Lleida (UdL) and the Institute …